BRAIN & PAIN Summit 2023
April 27-30, 2023
This conference will provide 15+ CE/CME credits hours
Register today for only $299!
Westin Kierland Resort & Spa
6902 E Greenway Pkwy
Scottsdale, AZ 85254
In a Hurry?Try our new express registration. Complete a simple registration now and update your profile later!
The BRAIN & PAIN Summit 2023 will convene April 27-30 at the prestigious Westin Kierland Resort & Spa in Scottsdale, Arizona. The agenda has been developed to address the most frequently treated CNS conditions seen by specialists and frontline clinicians. The 4-day conference will present 15+ CME/CE credit hours. Book the package! It includes Summit registration, 3 nights at the Kierland, taxes and resort fees. You’ll save $100 by booking everything together now!
Faculty subject to change.
Faculty and courses are subject to change. The online schedule below has the most up to date information.
We respect the value of your time and the complexities of arranging coverage for conference travel. At the BRAIN & PAIN Summit, you can experience the significance of peer-to-peer learning and earn 15+ CME/CE credit hours for this event.
**In addition to registration to the 4 day BRAIN & PAIN Summit, the hotel package includes a 3 night stay at the Westin Kierland Resort & Spa.
Westin Kierland Resort & Spa
6902 E Greenway Pkwy
Scottsdale, AZ 85254
This 4 star hotel is a serene oasis in the Sonoran Desert and is near dining and shopping at Kierland Commons. After all that learning, treat yourself to the golf club and an award-winning course designed by local architect Scott Miller. Plan to bring the kids? The OdySea Aquarium is nearby. Need a break from everything? Why not have a facial, massage, mani/pedi at Agave, The Arizona Spa & Salon. With Heavenly® Beds, high-speed internet access, complimentary bottled water, a coffee maker, a work desk, and flat screen TV to stream a movie, you can have it all!
The educational design of this activity addresses the needs of physicians, nurses, nurse practitioners, pharmacists, physician associates, psychologists, and allied HCPs who treat patients with various pain and/or neurological conditions.
Statement of Need/Program Overview
The BRAIN & PAIN Summit is a 3 1/2-day conference presenting 19.0 accredited CE hours developed for clinicians treating pain and other CNS conditions. Topic areas include, but are not limited to, dementia, epilepsy, sleep, stroke,movement and neurodegenerative disorders, CNS and PNS related pain conditions.
After completing this activity, the participant should be better able to:
1. Summarize the incidence rate and etiology of prevailing CNS disorders and chronic pain conditions
2. Describe reasons why differential diagnosis is imperative for CNS conditions and chronic pain disorders
3. Identify the social, economic, and health impacts of chronic pain and CNS disorders on both patients and caregivers
4. Recognize clinical pearls for varying disease states in the CNS and pain spaces
5. Recall approved and emerging therapies for CNS and pain disorders
- Alon Avidan, MD, MPH: Director, UCLA Sleep Disorders Center
- David Spencer, MD: Professor Of Neurology
- Eugene Vortsman, DO: Clinical Director Of Addiction Medicine And Disease Management
- Fiona Barwick, PhD, DBSM: Clinical Associate Professor
- Gregory M. Pontone, MD: Neuropsychiatry, Associate Professor
- Jay Salpekar, MD, FANPA, FAES, DFAACAP: Associate Professor Of Psychiatry And Neurology
- Kiran Patel, MD: Interventional Pain Medicine Specialist
- Merle Diamond, MD: President, Medical Director
- Michael R. Clark, MD, MPH, MBA: Professor Of Psychiatry And Behavioral Sciences
- Ramon Cuevas-Trisan, MD: Associate Chief Of Staff For Education & Research
- Sarah Kelley, MD: Director, Pediatric Epilepsy Monitoring Unit
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and BRAINWeek. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 19.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.0 MOC point amount medical knowledge MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 19.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Global Education Group designates this continuing education activity for 19.0 contact hour(s) (1.90 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-xxx-xx-xxx-xxx)
This is a knowledge based activity.
Psychology Accreditation Statement
Global Education Group (Global) is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. Global maintains responsibility for this program and its content.
This activity offers a maximum of 19 CE credits for psychologists. The instructional level of this activity is intermediate.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and BRAINWeek. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 19.0 contact hour(s) (which includes XX hour(s) of pharmacology).
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Instructions for Obtaining Credit
In order to receive credit, participants must complete each post-test for the activity they attended and complete the final evaluation. Participants must also score at least a 70% on the post-test and submit it. Statements of credit will be emailed within 4 to 6 weeks following the program.
Cancellation and Refund Policy
There is a fee for this educational activity.
Cancellations may be done online by clicking the following link: https://www.cvent.com/e.aspx?1T
Cancellations received online or in writing 14 or more days before the start of BRAIN & PAIN Summit will be refunded, less a $50 service charge per attendee. No refund will be made less than 14 days prior to the start of the BRAIN & PAIN Summit
You may transfer your registration to BRAIN & PAIN Summit to a colleague or future meeting until 7 days prior to the start of the BRAIN & PAIN Summit with the payment of a $50 service charge.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|Alon Y. Avidan, MD, MPH|
Consulting Fee (e.g. Advisory Board): IDORSIA; MERCK; TAKEDA; EISAI; HARMONY
Honoraria: IDORSIA; MERCK; HARMONY
Speaker’s Bureau: MERCK; IDORSIA
|Fiona Barwick, PhD||Nothing to disclose|
|Michael Clark, MD, MPH,, MBA||Nothing to disclose|
|Ramon Cuevas-Trisan, MD||Consulting Fee (e.g., Advisory Board): AbbVie, Hisamitsu|
Speaker’s Bureau: AbbVie
|Merle el Diamond, MD|
Consulting Fee: Lundbeck Pharmaceuticals, Amgen, Allergan, Abbvie, Assertio Therapeutics, Axsome Therapeutics, Biohaven Pharmaceuticals, Inc., BioDelivery Sciences International, Inc. (BDSI), Eli Lilly & Co., Impel Neuropharma, Promius Pharma, Supernus Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Satsuma Pharmaceuticals, Inc., Upsher-Smith Laboratories, Impel Neuro Pharma, Amneal Pharmaceuticals
Speakers Bureau: Amgen, Axsome Therapeutics, Allergan, Abbvie, Assertio Therapeutics, Biohaven Pharmaceuticals, Inc., Eli Lilly & Co., Impel Neuropharma, Lundbeck Pharmaceuticals, Supernus Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Upsher-Smith Laboratories
|Sarah Kelley, MD||Nothing to disclose|
|Kiran V. Patel, MD||Nothing to disclose|
|Gregory Pontone, MD||Consulting Fee (e.g. Advisory board): Acadia Pharmaceuticals Inc|
|Jay Salpekar, MD||Consulting Fee (e.g., Advisory Board): Cerevel Therapeutics |
Contracted Research: Jazz Pharmaceuticals
|David Spencer, MD||Consulting Fee (e.g., Advisory Board): NeuroPace, Inc |
Contracted Research (Principal Investigators must provide information, even if received by the institution): UCB; Neurona; NeuroPace
|Eugene Vortsman, DO||Nothing to disclose|
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at BRAINWeek have no relevant financial relationships to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and BRAINWeek do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities